Skip to main navigation
Logo - Color

    Top Bar Links

  • Who We Are
    • Who We Are
    • Leadership
    • Our Culture
  • Careers
  • Contact Us
    • Contact Us
    • General Inquiries
    • Clinical Trial Information
    • Medical Information Request
  • Our Science
    • Our Science
    • Pipeline
      • RAS Pathway
      • Avutometinib (RAF/MEK Clamp)
      • Defactinib (FAK Inhibitor)
      • Avutometinib as a Backbone of Therapy
    • Clinical Trials
    • Resources
  • Our Medicines
  • Medical Professionals
    • Overview
    • HCP Resources
      • Request Medical Information
      • Medical Education Grants and Scholarships
      • Investigator Sponsored Trials
      • Expanded Access
  • Patients & Advocacy
  • Investors & Media

    Investor Relations

    • Overview
    • News & Media
      • Press Releases
      • Media Resources
    • Events & Presentations
    • Corporate Governance
    • SEC Filings
    • Stock Information
    • IR Resources
  • Top Bar Links

  • Who We Are
    • Who We Are
    • Leadership
    • Our Culture
  • Careers
  • Contact Us
    • Contact Us
    • General Inquiries
    • Clinical Trial Information
    • Medical Information Request

SEC Filing Details

Document Details

Form
SCHEDULE 13G/A
Filing Date
Feb 17, 2026
Document Date
Feb 17, 2026
Form Description
SCHEDULE 13G/A - Description
Filing Group
Other
Company
Verastem, Inc.
Issuer
Verastem, Inc.

Filing Formats

View HTML
Download PDF
Download DOC
Download XLS
  • Terms of Use
  • Compliance & Ethics
  • Copyright Statement
  • Privacy Policy
  • Contact
  • Sitemap
Twitter Linkedin
Verastem logo

© 2026 Verastem, Inc. All Rights Reserved.